OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>RNA m<sup>6</sup>A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway</p>
Jiarong Cai, Fei Yang, Hailun Zhan, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 9143-9152
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang, Hengyou Weng, Jianjun Chen
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 270-288
Open Access | Times Cited: 929

The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang, Shan Kong, Mei Tao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 792

The role of m6A RNA methylation in cancer metabolism
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 473

Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 424

The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Paz Nombela, Borja Miguel‐López, Sandra Blanco
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 352

m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 257

Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou, Jiancheng Lv, Hao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 224

METTL3 plays multiple functions in biological processes.
Shuiping Liu, Lvjia Zhuo, Jianjun Wang, et al.
PubMed (2020) Vol. 10, Iss. 6, pp. 1631-1646
Closed Access | Times Cited: 159

Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 147

Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 140

Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 121

The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis
Mohammad B. Uddin, Zhishan Wang, Chengfeng Yang
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 104

METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey
Francesco Fiorentino, Martina Menna, Dante Rotili, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1654-1677
Open Access | Times Cited: 54

The biological function of m6A reader YTHDF2 and its role in human disease
Jinyan Wang, Ai-qing Lu
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 88

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
Daniela Barros‐Silva, João Lobo, Catarina Guimarães‐Teixeira, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 771-771
Open Access | Times Cited: 79

The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression
Shuiping Liu, Qiujie Li, Ke Chen, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 127, pp. 110098-110098
Open Access | Times Cited: 78

Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy
Pengfei Xu, Raoling Ge
European Journal of Medicinal Chemistry (2022) Vol. 230, pp. 114118-114118
Closed Access | Times Cited: 68

Roles of RNA Modifications in Diverse Cellular Functions
Emma Wilkinson, Yan‐Hong Cui, Yu‐Ying He
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 56

METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma
Zhiwei Zhang, Xufei Teng, Fu Zhao, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111530-111530
Open Access | Times Cited: 51

mRNA N6‐methyladenosine is critical for cold tolerance in Arabidopsis
Ganesan Govindan, Bishwas Sharma, Yong‐Fang Li, et al.
The Plant Journal (2022) Vol. 111, Iss. 4, pp. 1052-1068
Open Access | Times Cited: 50

METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis
Jun Liu, Junfang Yuan, Yuzhong Wang
Experimental Cell Research (2022) Vol. 416, Iss. 1, pp. 113149-113149
Closed Access | Times Cited: 45

m6A RNA Methylation: Ramifications for Gene Expression and Human Health
R. Karthiya, Piyush Khandelia
Molecular Biotechnology (2020) Vol. 62, Iss. 10, pp. 467-484
Open Access | Times Cited: 60

Comprehensive analysis of m6A regulators prognostic value in prostate cancer
Guangjie Ji, Cong Huang, Shiming He, et al.
Aging (2020) Vol. 12, Iss. 14, pp. 14863-14884
Open Access | Times Cited: 59

Page 1 - Next Page

Scroll to top